Digital Therapeutics

"DTx offer solutions in a number of very challenging spaces and access to care."

From the at-home ketamine experience to the Wit v United Behavioral Health reversal, here are highlights from the week in Psychiatric Times.

"As clinicians who took an oath to 'do no harm,' we must educate the public about the dangers and non–standard of care of the growing practice of at-home ketamine."

How can a robust understanding of the altered-state experience drive the development of therapeutic frameworks that are designed around that experience?

What are the challenges and opportunities for improvement in COVID-19-related mental health care?

Considering challenges and opportunities in digital health solutions for mental health care.

Experts discuss psychiatry’s role in the advancement of AI technologies at the 2022 APA Annual Meeting.

Learn what potential challenges come with mHealth apps and how to overcome them to best fit patient needs.

How can these mHealth apps help in the treatment of depression?

How can mHealth apps help overcome barriers to access to care?

Digital therapeutics may be poised to step up as the next CBT.

The experts weighed in on a wide variety of psychiatric issues for the first Psychiatric Times issue of 2022.

Study also suggests link between postpartum depression and insomnia.

App allows users with serious mental illness to create and share a psychiatric advance directive.

New approaches to ensure that the brain health technology sector continues to flourish for decades.

Research shows potential for increased patient engagement and limited support for improved retention rates.

What will psychiatric practice look like in the future?

Is the solution to health care professional burnout in our phones?

At the Annual Psychiatric Times World CME Conference, an all-star lineup of presenters will share their latest research. Check out this preview of the full agenda.

43 of 50 states are experiencing a severe shortage in psychiatrists specializing in child and adolescent care. Telehealth may be able to help.

Here’s how a digital mental health ecosystem can seamlessly connect and support all facets of mental health care.

A new digital therapeutic helps patients with psychosis to slow down and manage their fears.

A kappa-opioid receptor with psychedelic effects, this potential agent for treatment-resistant depression and other disorders will be paired with a digital therapeutic for maximum efficacy.

Digital therapeutics require adoption from 3 groups: psychiatrists, payers, and patients. What needs to be done to get everyone aboard?

What products have broken ground in the digital therapeutics space, and how can they help patients?

Close to a third of adults in Western countries report trouble with sleep. Digital cognitive behavioral therapy may be a treatment solution...

Key questions to consider when evaluating a digital therapeutic for anxiety.

Artificial intelligence and natural language processing provide powerful new tools to measure thought disorder and negative symptoms in schizophrenia.

We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?

What will psychiatric practice look like in the year 2030?